Health AI Central
Peer-Reviewed Publication
Methods Mol Biol2026;3036387-407.January 1, 2026Journal Article

Image Analysis Approaches for In Situ Hybridization Technologies.

David Mason1, Julia Jones2
1Visiopharm A/S, Agern Allé 24, 2970, Hoersholm, Denmark. dma@visiopharm.com.
2Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
PubMed DOI

Abstract

In situ hybridisation (ISH) is an invaluable experimental technique when considering the holistic process of transcription through to translation. Without good tools to identify sequence-based structures within cells and tissues, researchers are left with only half of the story when looking at protein expression. While there are many experimental approaches, including a rainbow of chromogens and a…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.